Navigation Links
Regenstrief and IU study investigates older adults' views on cancer screening
Date:3/11/2013

INDIANAPOLIS -- A study from the Regenstrief Institute and the Indiana University Center for Aging Research has found that many older adults are hesitant to halt cancer screenings even when the screenings may no longer be beneficial or may even be potentially harmful. The study is among the first to explore older adults' perceptions of recommendations to halt screenings for breast, prostate, colon and other cancers as they age.

"Older Adults and Forgoing Cancer Screening: 'I think it would be strange'" was published Online First by JAMA Internal Medicine. "I think it would be strange" was an older adult's reaction when asked about a physician advising against a screening.

The researchers -- led by Regenstrief Institute investigator Alexia Torke, M.D., an IU Center for Aging Research scientist and an assistant professor of medicine at the IU School of Medicine -- report that many older adults feel a strong moral obligation to continue cancer screenings and that a physician's recommendation to stop screening might threaten trust in the doctor or motivate the patient to seek a second opinion.

"In this era of attention to over-testing, there is a growing recognition in the medical community that some older adults are screened for cancer when it is not beneficial or even potentially harmful to that person," Dr. Torke said. "If physicians are going to successfully communicate with their older patients about forgoing screening they, as well as other care providers, need to understand how older adults view these screenings."

In open-ended interviews with older adults with a mean age of 76, the researchers found patients viewed screening as an automatic, recommended or obligatory action. According to Dr. Torke, this confirms the success of public health campaigns in communicating the health benefits of screening. The study findings, she says, highlight the need to develop specific messages for older adults that don't undermine the messages targeted to other groups.

However, study participants seemed to respond well to the idea that screening does not make sense if the burdens -- such as pain, time requirements or stress -- can be expected to outweigh the benefits. For example, the burdens of colonoscopy were repeatedly cited as reasons not to continue with this test as the patient aged.

Participants were skeptical about hearing government panel recommendations and statistics that show that older adults may not benefit from certain screening tests. Many expressed distrust of the government or felt statistics did not apply to them.

Study participants ranged in age from 63 to 90.

"Each patient is different, but when speaking with older adults or the caregivers of those who can no longer make decisions for themselves about reducing screenings, the discussion needs to clearly outline the balance of risks and benefits for the specific individual. This approach has the greatest chance of building trust and understanding," Dr. Torke said.


'/>"/>
Contact: Cindy Fox Aisen
caisen@iupui.edu
317-843-2276
Indiana University
Source:Eurekalert  

Related medicine news :

1. Regenstrief study: Informatics tools underutilized in prevention of hospital-acquired infection
2. Regenstrief investigator inducted into medical informatics honor society
3. Regenstrief study finds that generic drugs often have incorrect safety labeling
4. Merck and Regenstrief Institute establish evidence-based care collaboration
5. Regenstrief and IHTSDO start collaborative efforts
6. IU, Regenstrief automated system aims to improve child health
7. Seniors Getting Unnecessary Colonoscopies: Study
8. Experimental Alzheimers Drug Shows Promise, Study Finds
9. Common erectile dysfunction drug not helpful for heart failure patients, study finds
10. Study finds fat and bone mass are genetically linked
11. New study explores link between status and health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Regenstrief and IU study investigates older adults' views on cancer screening
(Date:1/23/2017)... ... January 23, 2017 , ... The Masters of Science ... evaluation leaders with decades of experience who remain current practitioners in the field. ... system, there is a renewed demand for versatile, data-driven leadership.The American University’s MS ...
(Date:1/23/2017)... ... January 23, 2017 , ... Moisture measurement is a ... method is paramount to success. Selecting an inappropriate measurement method can cause costly ... use the same equipment. Rare or expensive substances are wasted and production may ...
(Date:1/23/2017)... ... January 23, 2017 , ... Gynecology Associates of ... gynecological services for women of all ages. The staff of Gynecology ... of reproductive services from routine health screenings to diagnosing and treating female concerns ...
(Date:1/23/2017)... ... ... “Some Infallible Characteristics of Christ”: a fascinating and entrancing novel exploring the ... of published author, Rev. Dr. Robert W. Thomas, the third of seven siblings. He ... nineteen, a pastor for over fifteen years. He is a graduate of N.C. College ...
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing through hospitals and ... a simple test will take days to arrive to the end customer, having to ... access to their lab tests, bypassing the cost and delay of traditional means. Now ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Jan 23, 2017 Research and Markets has announced ... Trends - Product - Forecast to 2025" report to their offering. ... Report Highlights: ... market trends to identify the investment opportunities Market forecasts ... Key market trends across the business segments, Regions and Countries ...
(Date:1/23/2017)... Jan. 23, 2017  Using Astute Medical,s ... risk for acute kidney injury (AKI) after open-heart ... care guidelines significantly improved outcomes by ... more than 33 percent, according to a ... Intensive Care Medicine. Experience ...
(Date:1/23/2017)... January 23, 2017 Ahead of today,s trading ... how they have fared at the close: Kite Pharma Inc. (NASDAQ: ... OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... were relative laggards on Friday, January 20 th , 2017, down ... research reports on these stocks now at: ...
Breaking Medicine Technology: